Using the Inventory of Depressive Symptoms Scales (IDS-C and IDS-SR) in Clinical Research

Join our featured speakers to learn about using the Inventory of Depressive Symptoms (IDS) questionnaire in clinical research/practice to assess the severity of depressive symptoms.

Attend this webinar to:

• Learn the rationale and methods used in developing the IDS in both clinician-rated (IDS-C) and patient self-reported (IDS-SR) formats
• Get insights on the psychometric features of the IDS instrument and how it compares to other commonly used clinician-rated scales

The IDS was developed to make improvements on the available clinician and patient ratings by providing equivalent weightings for each symptom item; providing clearly stated anchors that estimate the frequency and severity of symptoms; including all DSM-V criterion items required to diagnose a major depressive episode; and providing matched clinician and patient ratings.

Dr. A. John Rush, the author of the health research questionnaire, will provide a brief description of the IDS and how the instrument can be used in clinical research/practice to assess depressive symptom severity. Resulting assessments can be used to screen for depression, although they have been used predominantly as measures of symptom severity.  He will also review both the rationale and methods entailed in developing the Inventory of Depressive Symptoms (IDS) in both clinician-rated (IDS-C) and self-reported (IDS-SR) formats. Psychometric features of the both the IDS-C and IDS-SR will be presented. These scales are compared to the Hamilton Rating Scale for Depression (HRS-D) in the detection of symptom change in patients with major depressive or bipolar disorder. The face validity and established psychometric features of the IDS-C and IDS-SR indicate that either may be useful in detecting symptom change, as well as in detecting residual symptoms in depressed patients.

Register today to learn more about the IDS health research instrument and how to gain access for use in clinical research or academia.

Mapi Research Trust is the official licensor and distributor of more than 300 COAs, on behalf of their developers and copyright owners. Please visit our catalog to access the complete list of COAs managed by Mapi Research Trust, or visit our website for additional information on our services to developers and copyright owners.

Speakers

A. John Rush, MD, Adjunct Professor Duke University School of Medicine, Durham NC, Adjunct Professor Texas Tech Health Sciences Center, Permian Basin TX, and CEO Curbstone Consultant LLC., Duke-NUS Medical School

Dr. Rush is the author of the Inventory of Depressive Symptoms (IDS), originally published in 1986. His research has focused on the development and testing of innovative treatments for depressive and bipolar disorders, including medications, medication combinations, somatic treatments, psychotherapy and disease management protocols. He has authored more than 800 professional publications and has received awards from the American College of Psychiatrists, American Psychopathological Association, the National Alliance for Research in Schizophrenia and Affective Disorders, the American Psychiatric Association and the Society for Biological Psychiatry, among others. He provides consultation to individuals, academic, governmental and industrial organizations in research design and academic career development.

Message Presenter

Piero Bindi, Author Relations Specialist, Author Collaboration Unit, Mapi Research Trust

Piero Bindi is an Author Relations Specialist who manages health research questionnaire distribution and licensing for Mapi Research Trust.

Message Presenter